Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Cash from Investing Activities (2020 - 2026)

Climb Bio filings provide 7 years of Cash from Investing Activities readings, the most recent being -$13.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 69.7% to -$13.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $32.6 million through Mar 2026, up 118.37% year-over-year, with the annual reading at $2.8 million for FY2025, 102.34% up from the prior year.
  • Cash from Investing Activities hit -$13.0 million in Q1 2026 for Climb Bio, down from $25.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $36.7 million in Q4 2023 and bottomed at -$71.8 million in Q3 2024.
  • Average Cash from Investing Activities over 5 years is -$1.6 million, with a median of $5.8 million recorded in 2023.
  • The largest annual shift saw Cash from Investing Activities surged 277.34% in 2022 before it tumbled 502.44% in 2024.
  • Climb Bio's Cash from Investing Activities stood at $14.3 million in 2022, then surged by 157.37% to $36.7 million in 2023, then crashed by 245.34% to -$53.4 million in 2024, then skyrocketed by 147.82% to $25.5 million in 2025, then crashed by 150.73% to -$13.0 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Cash from Investing Activities are -$13.0 million (Q1 2026), $25.5 million (Q4 2025), and $15.3 million (Q3 2025).